{"id":"standard-of-care-double-oral","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Dyspepsia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Double oral therapy typically refers to a combination of oral antiplatelet agents (such as aspirin and clopidogrel) or an oral anticoagulant with an antiplatelet agent, used to reduce the risk of thrombotic complications in cardiovascular conditions. The exact mechanism depends on the specific drug combination, but generally involves inhibition of platelet aggregation and/or coagulation cascade to prevent clot formation.","oneSentence":"This is a standard-of-care dual oral antithrombotic regimen combining two antiplatelet or anticoagulant agents to prevent thrombotic events.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:09:24.158Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Post-percutaneous coronary intervention"},{"name":"Atrial fibrillation with additional thrombotic risk"}]},"trialDetails":[{"nctId":"NCT05754957","phase":"PHASE3","title":"A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-07","conditions":"Acute Coronary Syndrome","enrollment":14194},{"nctId":"NCT06948097","phase":"PHASE1","title":"Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies","status":"NOT_YET_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2026-04-01","conditions":"Lung Transplantation","enrollment":30},{"nctId":"NCT04781387","phase":"PHASE2","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Crestone, Inc","startDate":"2021-01-05","conditions":"Clostridioides Difficile Infection","enrollment":43},{"nctId":"NCT07496034","phase":"PHASE3","title":"Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial","status":"RECRUITING","sponsor":"Tsai, Chueh-Yi, MD","startDate":"2025-07-01","conditions":"Episodic Migraine","enrollment":40},{"nctId":"NCT07047144","phase":"PHASE2","title":"A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy","status":"RECRUITING","sponsor":"Scholar Rock, Inc.","startDate":"2025-09-15","conditions":"Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2","enrollment":52},{"nctId":"NCT07033039","phase":"NA","title":"Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre","status":"RECRUITING","sponsor":"University of Nove de Julho","startDate":"2026-01-30","conditions":"Rhinoplasty, Edema","enrollment":60},{"nctId":"NCT06890598","phase":"PHASE3","title":"Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-03-27","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":700},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT06587945","phase":"PHASE4","title":"Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment","status":"RECRUITING","sponsor":"Center for Eye Research Australia","startDate":"2025-09-19","conditions":"Retinal Detachment","enrollment":144},{"nctId":"NCT07241390","phase":"PHASE3","title":"A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-12-01","conditions":"Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease","enrollment":7140},{"nctId":"NCT07169851","phase":"PHASE2","title":"A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-11-28","conditions":"Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions","enrollment":204},{"nctId":"NCT06641466","phase":"PHASE3","title":"A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-03-11","conditions":"Menstrual Migraine","enrollment":723},{"nctId":"NCT07355218","phase":"PHASE3","title":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)","status":"NOT_YET_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2026-03-27","conditions":"Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus","enrollment":202},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT05268289","phase":"PHASE2","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-10","conditions":"Lupus Nephritis","enrollment":240},{"nctId":"NCT07332481","phase":"PHASE3","title":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease","status":"NOT_YET_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2026-03-27","conditions":"Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)","enrollment":202},{"nctId":"NCT05401201","phase":"NA","title":"Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Koite Health Oy","startDate":"2023-02-24","conditions":"Oral Lichen Planus, Dental Plaque, Oral Bacterial Infection","enrollment":60},{"nctId":"NCT07225621","phase":"PHASE2","title":"Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"Alpheus Medical, Inc.","startDate":"2026-01-28","conditions":"Glioblastoma, GBM","enrollment":103},{"nctId":"NCT04175600","phase":"PHASE3","title":"A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actelion","startDate":"2020-01-16","conditions":"Hypertension, Pulmonary","enrollment":138},{"nctId":"NCT07007312","phase":"PHASE3","title":"Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML","status":"RECRUITING","sponsor":"Kura Oncology, Inc.","startDate":"2025-09-26","conditions":"Acute Myeloid Leukemia (AML)","enrollment":1300},{"nctId":"NCT05639556","phase":"","title":"Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2023-04-20","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT07227454","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2026-01-08","conditions":"Depressive Disorder, Major","enrollment":258},{"nctId":"NCT05702034","phase":"PHASE3","title":"A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-02-15","conditions":"Ischemic Stroke; Ischemic Attack, Transient","enrollment":15000},{"nctId":"NCT05558267","phase":"NA","title":"Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"NYU Langone Health","startDate":"2027-01-15","conditions":"End Stage Kidney Disease","enrollment":20},{"nctId":"NCT03626688","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2018-08-30","conditions":"PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension","enrollment":687},{"nctId":"NCT07460154","phase":"NA","title":"Structured Review: To Optimise Management and Prevent Harm in COPD","status":"NOT_YET_RECRUITING","sponsor":"Northumbria Healthcare NHS Foundation Trust","startDate":"2026-03-01","conditions":"COPD","enrollment":96},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT06952803","phase":"PHASE3","title":"A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-08-06","conditions":"Prostate Cancer","enrollment":700},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT04206553","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2020-10-28","conditions":"Bullous Pemphigoid","enrollment":106},{"nctId":"NCT05894239","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2023-09-08","conditions":"Metastatic Breast Cancer","enrollment":230},{"nctId":"NCT06047379","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis","status":"RECRUITING","sponsor":"Neonc Technologies, Inc.","startDate":"2023-11-01","conditions":"Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult","enrollment":134},{"nctId":"NCT07436130","phase":"NA","title":"Curcumin in Critically Ill Patients With Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Hospital Civil de Guadalajara","startDate":"2026-03-01","conditions":"Sepsis","enrollment":56},{"nctId":"NCT07022678","phase":"PHASE3","title":"Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-08-08","conditions":"Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia","enrollment":556},{"nctId":"NCT04736199","phase":"PHASE3","title":"Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-02-23","conditions":"Prostatic Neoplasms","enrollment":669},{"nctId":"NCT05254990","phase":"PHASE3","title":"Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-04-27","conditions":"Infectious Pneumonia, Severe COVID-19","enrollment":414},{"nctId":"NCT07406971","phase":"PHASE2","title":"Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-09-01","conditions":"Ischemic Stroke","enrollment":46},{"nctId":"NCT05047263","phase":"PHASE3","title":"A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-09-21","conditions":"Non-diabetic Chronic Kidney Disease","enrollment":1584},{"nctId":"NCT07407400","phase":"PHASE4","title":"Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-04-01","conditions":"Sleep Disturbance, Delirium, Critical Illness","enrollment":100},{"nctId":"NCT04485949","phase":"PHASE2","title":"A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Imvax","startDate":"2023-03-20","conditions":"Glioblastoma","enrollment":93},{"nctId":"NCT07215273","phase":"PHASE2","title":"Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections","status":"RECRUITING","sponsor":"Elion Therapeutics, Inc.","startDate":"2026-02","conditions":"Suspected Invasive Mould Infection","enrollment":80},{"nctId":"NCT07142291","phase":"PHASE2","title":"PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS","status":"RECRUITING","sponsor":"PhenoNet, Inc.","startDate":"2025-11-25","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":105},{"nctId":"NCT06072482","phase":"PHASE4","title":"A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis","status":"RECRUITING","sponsor":"Amgen","startDate":"2024-02-07","conditions":"Antineutrophil Cytoplasmic Antibody-associated Vasculitis","enrollment":300},{"nctId":"NCT07377032","phase":"PHASE3","title":"TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders","status":"RECRUITING","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2025-08-29","conditions":"GRIN-related Disorders, GRIN1, GRIN2A","enrollment":40},{"nctId":"NCT05300932","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tongji Hospital","startDate":"2022-03-08","conditions":"Systemic Sclerosis","enrollment":60},{"nctId":"NCT07369284","phase":"PHASE2","title":"Melatonin for Glycemic Control in Gestational Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Obstetrics & Gynecology Hospital of Fudan University","startDate":"2026-02","conditions":"Gestational Diabetes","enrollment":150},{"nctId":"NCT06703476","phase":"PHASE3","title":"A Study of Surgical Techniques During Cystectomy","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-11-21","conditions":"Bladder Cancer","enrollment":530},{"nctId":"NCT04137107","phase":"PHASE2, PHASE3","title":"Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2020-06-17","conditions":"Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8","enrollment":220},{"nctId":"NCT04564547","phase":"PHASE2","title":"Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-03-09","conditions":"HIV-1 Infection","enrollment":161},{"nctId":"NCT06846320","phase":"PHASE2","title":"Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-04-29","conditions":"Generalized Anxiety Disorder (GAD)","enrollment":315},{"nctId":"NCT05278416","phase":"NA","title":"Regular Home Use of Dual-light Photodynamic Therapy in the Management of Chronic Periodontitis","status":"COMPLETED","sponsor":"Koite Health Oy","startDate":"2022-02-08","conditions":"Periodontitis","enrollment":202},{"nctId":"NCT05825742","phase":"NA","title":"Regular Home Use of Dual-light Photodynamic Therapy on Oral Health in Adolescents Undergoing Fixed Orthodontic Treatment","status":"COMPLETED","sponsor":"Koite Health Oy","startDate":"2023-09-05","conditions":"Orthodontic Appliance Complication, Plaque, Dental, Gingival Inflammation","enrollment":40},{"nctId":"NCT07329946","phase":"NA","title":"Immuno-inflammatory Response of Erdosteine in COPD","status":"NOT_YET_RECRUITING","sponsor":"Pierachille Santus, MD, PhD","startDate":"2026-02-28","conditions":"COPD","enrollment":30},{"nctId":"NCT02296125","phase":"PHASE3","title":"AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-12-03","conditions":"Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer","enrollment":674},{"nctId":"NCT07276204","phase":"PHASE2","title":"Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"NOT_YET_RECRUITING","sponsor":"Southern California Institute for Research and Education","startDate":"2026-03-31","conditions":"MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":70},{"nctId":"NCT07298759","phase":"NA","title":"The Effect of Hydroxytyrosol Administration on Superoxide Dismutase, Pulsatility Index and Resistance Index of Uterine Artery Doppler and Flow-Mediated Dilatation of Brachial Artery In Mothers With Hypertension In Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr Cipto Mangunkusumo General Hospital","startDate":"2025-06-11","conditions":"Hypertension in Pregnancy","enrollment":52},{"nctId":"NCT07315256","phase":"NA","title":"Combined Ultrasonographic Skin-to-Epiglottis Distance With Modified Mallampati Versus Modified Mallampati Score Alone in Predicting Difficult Laryngoscopy During Tracheal Intubation Under General Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-01","conditions":"Ultrasonographic, Mallampati Score, Mallampati Score, Difficult Intubation, Videolaryngoscope","enrollment":160},{"nctId":"NCT03602859","phase":"PHASE3","title":"A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tesaro, Inc.","startDate":"2018-10-11","conditions":"Ovarian Neoplasms, Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma","enrollment":1400},{"nctId":"NCT07309094","phase":"","title":"Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2023-09-15","conditions":"Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 1","enrollment":250},{"nctId":"NCT07267260","phase":"PHASE2","title":"Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"King Edward Medical University","startDate":"2025-12-16","conditions":"Cirrhoses, Liver","enrollment":154},{"nctId":"NCT05640336","phase":"NA","title":"Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2023-03-03","conditions":"Periprosthetic Joint Infection","enrollment":490},{"nctId":"NCT06903156","phase":"PHASE2","title":"Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2021-11-15","conditions":"Primary Open-Angle Glaucoma (POAG)","enrollment":102},{"nctId":"NCT03615326","phase":"PHASE3","title":"Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-05","conditions":"Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma","enrollment":738},{"nctId":"NCT04882878","phase":"PHASE2","title":"A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-08-20","conditions":"Systemic Lupus Erythematosus","enrollment":228},{"nctId":"NCT05162586","phase":"PHASE2","title":"The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)","status":"COMPLETED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2022-03-31","conditions":"Systemic Lupus Erythematosus","enrollment":456},{"nctId":"NCT06857487","phase":"PHASE1, PHASE2","title":"Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2025-06-13","conditions":"Acute Ischemic Stroke","enrollment":72},{"nctId":"NCT06207370","phase":"PHASE2","title":"Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis","status":"RECRUITING","sponsor":"60 Degrees Pharmaceuticals LLC","startDate":"2024-06-17","conditions":"Babesiosis","enrollment":33},{"nctId":"NCT07242443","phase":"PHASE4","title":"Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Pylori）","status":"NOT_YET_RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2025-11-20","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":240},{"nctId":"NCT04250922","phase":"PHASE2, PHASE3","title":"LAM561 With RT and TMZ for Adults With Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Laminar Pharmaceuticals","startDate":"2019-12-01","conditions":"Primary Glioblastoma, Glioblastoma Multiforme","enrollment":144},{"nctId":"NCT06694337","phase":"NA","title":"Study to Investigate the Potential Pharmacological Effect of Oral Palmitoylethanolamide (PEA) Therapy in the Management of Low Back Pain (Neuropathic Pain)","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-01-28","conditions":"Low Back Pain","enrollment":120},{"nctId":"NCT04713657","phase":"PHASE1","title":"Beta-blocker Administration for Cardiomyocyte Division","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-12-16","conditions":"Tetralogy of Fallot, Double Outlet Right Ventricle","enrollment":40},{"nctId":"NCT07227649","phase":"PHASE2","title":"NAC-REPAIR for Post-surgical Pain","status":"NOT_YET_RECRUITING","sponsor":"University of Arizona","startDate":"2026-01-15","conditions":"Carpal Tunnel Surgery, Trigger Finger Disorder, De Quervain Syndrome","enrollment":80},{"nctId":"NCT03482297","phase":"PHASE1, PHASE2","title":"Automated Abdominal Binder for Orthostatic Hypotension","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2018-03-01","conditions":"Orthostatic Hypotension, Autonomic Failure, Pure Autonomic Failure","enrollment":31},{"nctId":"NCT04968912","phase":"PHASE2","title":"A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-21","conditions":"Sjogren's Syndrome","enrollment":163},{"nctId":"NCT06522997","phase":"PHASE2","title":"A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2024-08-08","conditions":"Chronic Kidney Disease","enrollment":700},{"nctId":"NCT05103332","phase":"PHASE2","title":"Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)","status":"COMPLETED","sponsor":"Alnylam Pharmaceuticals","startDate":"2021-11-05","conditions":"Hypertension","enrollment":663},{"nctId":"NCT05496868","phase":"PHASE2","title":"Add-on Reparixin in Adult Patients With ARDS","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-12-06","conditions":"Acute Respiratory Distress Syndrome, Adult","enrollment":66},{"nctId":"NCT02677896","phase":"PHASE3","title":"A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2016-03-09","conditions":"Metastatic Hormone Sensitive Prostate Cancer","enrollment":1150},{"nctId":"NCT05901831","phase":"PHASE3","title":"A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes","status":"COMPLETED","sponsor":"Bayer","startDate":"2024-02-26","conditions":"Chronic Kidney Disease, Type 1 Diabetes Mellitus","enrollment":241},{"nctId":"NCT06392841","phase":"PHASE2","title":"Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations","status":"WITHDRAWN","sponsor":"Qian Qin","startDate":"2025-10","conditions":"Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Deleterious HRR Gene Mutation, BRCA1 Gene Mutation","enrollment":""},{"nctId":"NCT05097989","phase":"PHASE2","title":"Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)","status":"TERMINATED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2022-01-14","conditions":"Lupus Nephritis, Immunoglobulin A Nephropathy, IgAN","enrollment":100},{"nctId":"NCT04718389","phase":"PHASE3","title":"A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-01-26","conditions":"Asthma","enrollment":1719},{"nctId":"NCT05508074","phase":"PHASE2","title":"Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)","status":"COMPLETED","sponsor":"InFlectis BioScience","startDate":"2022-12-02","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":51},{"nctId":"NCT05382312","phase":"PHASE2","title":"Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-07-26","conditions":"Tuberculosis","enrollment":127},{"nctId":"NCT05564169","phase":"PHASE3","title":"Masitinib in Patients With Mild Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"AB Science","startDate":"2026-06","conditions":"Alzheimer Disease","enrollment":600},{"nctId":"NCT07174492","phase":"PHASE3","title":"Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients","status":"NOT_YET_RECRUITING","sponsor":"AB Science","startDate":"2026-01-01","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":412},{"nctId":"NCT04582136","phase":"PHASE3","title":"Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2021-03-04","conditions":"Systemic Lupus Erythematosus","enrollment":146},{"nctId":"NCT06497465","phase":"PHASE3","title":"Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-09-18","conditions":"Tuberculosis, HIV","enrollment":150},{"nctId":"NCT03731260","phase":"PHASE2","title":"(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Blueprint Medicines Corporation","startDate":"2019-04-16","conditions":"Indolent Systemic Mastocytosis","enrollment":251},{"nctId":"NCT07148960","phase":"PHASE4","title":"Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?","status":"ENROLLING_BY_INVITATION","sponsor":"West Virginia University","startDate":"2025-09-15","conditions":"Staphylococcus Aureus Bacteremia","enrollment":300},{"nctId":"NCT07169916","phase":"NA","title":"Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-09-01","conditions":"Biliary Tract Cancer (BTC)","enrollment":210},{"nctId":"NCT07144956","phase":"PHASE3","title":"Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2025-12-15","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":630},{"nctId":"NCT07163702","phase":"PHASE2","title":"Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2025-10-01","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT06721585","phase":"","title":"Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-07-10","conditions":"Mpox (Monkeypox)","enrollment":328},{"nctId":"NCT07151313","phase":"NA","title":"Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis:","status":"NOT_YET_RECRUITING","sponsor":"Sinai University","startDate":"2025-09-15","conditions":"Chronic Sinusitis, Acute Sinusitis, Rhinosinusitis","enrollment":30},{"nctId":"NCT04643158","phase":"PHASE2","title":"Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2021-03-12","conditions":"Asthma","enrollment":72},{"nctId":"NCT07139964","phase":"NA","title":"High-Dose Vitamin D3 for Diabetic Foot Ulcer Healing: Randomized Controlled Trial","status":"COMPLETED","sponsor":"Universitas Sriwijaya","startDate":"2024-07-01","conditions":"Diabetic Foot Ulcer, Vitamin D Deficiency, Wound Healing Disorder","enrollment":24},{"nctId":"NCT07138014","phase":"PHASE2","title":"FHND1002 for ALS Treatment: Phase 2","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","startDate":"2025-10-01","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":180},{"nctId":"NCT04521803","phase":"PHASE2","title":"High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis","status":"RECRUITING","sponsor":"University of Cape Town","startDate":"2022-01-10","conditions":"Tuberculous Pericarditis, HIV Status","enrollment":60},{"nctId":"NCT07130617","phase":"PHASE1","title":"Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-09-29","conditions":"Efficacy, Safety, Megestrol Acetate","enrollment":132}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard of Care - Double Oral","genericName":"Standard of Care - Double Oral","companyName":"AOP Orphan Pharmaceuticals AG","companyId":"aop-orphan-pharmaceuticals-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a standard-of-care dual oral antithrombotic regimen combining two antiplatelet or anticoagulant agents to prevent thrombotic events. Used for Acute coronary syndrome, Post-percutaneous coronary intervention, Atrial fibrillation with additional thrombotic risk.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}